All systems operational
Q2 2011

Can we use GP73 as a biomarker for the detection of hepatocellular carcinoma?

Dalia Omran · Serag Esmat · Heba Sedrac · Ahmad ElBadry · Dina Ismail · Laila Rashed
10.1097/01.elx.0000397027.33294.16 394 Views 0 Citations
0
Citations
394
Views
Abstract not available for this publication.
Cite this Article (APA)
Dalia, O., Serag, E., Heba, S., Ahmad, E., Dina, I., Laila, R. (2011). Can we use GP73 as a biomarker for the detection of hepatocellular carcinoma?. Egyptian Liver Journal. https://doi.org/10.1097/01.elx.0000397027.33294.16
Related Papers
Comparison between transient elastography (Fibroscan) and liver biopsy for the diagnosis of hepatic …
Gamal Shiha; Seham Seif; Maha Maher; Shahera Etreby; Waleed Samir; Khaled Zalata · 2014
10
cites
415
Tissue microarray as a research tool to study non-neoplastic liver diseases
Mohamed H. Abdel-Rahman; Ahmad A. Agour; Dina S. El-Azab · 2014
9
cites
410
Prevention of paracentesis-induced circulatory dysfunction
Ayman Alsebaey; Wael Abdel-Razek; Ashraf Bassuni; Eman Rewisha; Magdy Khalil; Im · 2013
5
cites
417
Prevalence of hepatitis C virus in an elderly population in rural areas of Sharkia governorate, Egyp…
Mohamed Emam; Mohamed I. Radwan; Mohamed M. Refaey; Noha E. Shaheen; Safaa Abd-E · 2015
5
cites
412
Access
View Full Text via DOI
Published in
ISSN 2090-6218
Quartile Q2
AMS Score 93
Field Medicine & Health Sciences
Publisher Springer Nature / SpringerOpen
Country 🇪🇬 Egypt
View Journal Profile →
Authors
Publication Details
Year 2011
Language English
Added 11 Aug 2026